VKTX Stock Flat After 22% Weight Loss Win: Why Is Viking Therapeutics’ No-Plateau GLP-1 Data Being Ignored?
Viking Therapeutics' VK2735 hit 22% weight loss at week 33 with no plateau observed, yet VKTX stock barely moved after the release. The disconnect between...
